Literature DB >> 9180146

Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993.

T Bjørge1, A Engeland, S Hansen, C G Tropé.   

Abstract

Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumours in Norway were examined, based on data from the population-based Cancer Registry of Norway. A total of 14,352 cases of ovarian cancer were diagnosed between 1954-1993, of which 94% of the histologically verified ovarian cancers were epithelial tumours. The age-adjusted incidence rate rose from 10 per 100,000 person-years in 1954-1958 to a peak of 14 per 100,000 person-years in 1984-1988. In women older than 50 years, there was an increasing trend in incidence rates during the entire study period. From the cohort perspective, the largest increase was observed among women born between 1870-1899. A total of 2,343 borderline tumours was diagnosed between 1970-1993. The age-adjusted incidence rate has increased since 1970, reaching 4.8 per 100,000 person-years in 1989-1993.

Entities:  

Mesh:

Year:  1997        PMID: 9180146     DOI: 10.1002/(sici)1097-0215(19970529)71:5<780::aid-ijc15>3.0.co;2-c

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Authors:  C Winchester; S Robertson; T MacLeod; K Johnson; M Thomas
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 2.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

3.  Borderline ovarian tumor in pregnancy: can surgery wait? A case series.

Authors:  Ailyn M Vidal Urbinati; Anna D Iacobone; Raffaela C Di Pace; Ida Pino; Maria R Pittelli; Maria E Guerrieri; Eleonora P Preti; Dorella Franchi
Journal:  Arch Gynecol Obstet       Date:  2021-05-05       Impact factor: 2.344

4.  Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.

Authors:  Ipsita Mohapatra; Subha R Samantaray; Nikku Harshini
Journal:  Cureus       Date:  2022-04-13

5.  Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms.

Authors:  F Levi; C La Vecchia; L Randimbison; V C Te
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

6.  Ovarian cancer histology-specific incidence trends in Canada 1969-1993: age-period-cohort analyses.

Authors:  J Zhang; A M Ugnat; K Clarke; Y Mao
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

7.  BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.

Authors:  T Bjørge; A K Lie; E Hovig; R E Gislefoss; S Hansen; E Jellum; H Langseth; K Nustad; C G Tropé; A Dørum
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

8.  Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study.

Authors:  M Kumle; E Weiderpass; T Braaten; H-O Adami; E Lund
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

Review 9.  Controversies in borderline ovarian tumors.

Authors:  Seok Ju Seong; Da Hee Kim; Mi Kyoung Kim; Taejong Song
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

10.  Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012.

Authors:  Idlir Licaj; Marko Lukic; Mie Jareid; Eiliv Lund; Tonje Braaten; Inger Torhild Gram
Journal:  Cancer Med       Date:  2016-01-14       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.